Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001650131-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | — | +30.2K | 33.8K | +847% | — |
| D | 2026-03-17 | 2026-03-16 | MIRM | Radovich Peter | Pres AND COO | S - Sale+OE | $91.98 | -16.5K | 40.3K | -29% | -$1.52M |
| DM | 2026-03-17 | 2026-03-15 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $0.00 | -30.2K | 11.5K | -72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 23,000 | — | 56,787 | D | — | — | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-16 | S | D | 16,515 | $91.98 | 40,272 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 7,220 | — | 33,787 | D | — | — | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 4 | Derivative | Performance Restricted Stock Units | 2026-03-15 | M | D | 7,220 | $0.00 | 0 | D | — · — to — | 7,220 Common Stock | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. |
| 5 | Derivative | Performance Restricted Stock Units | 2026-03-15 | M | D | 23,000 | $0.00 | 11,500 | D | — · — to — | 23,000 Common Stock | (F1) Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. |